AHSP (1999) Best practices for health-system pharmacy: positions and practice standards of ASHP 1999-2000. American Society for Health-System Pharmacists, Bethesda, MD. ISBN: 1-979907-99-2.

Avorn J, Soumerai SB, Taylor W, et al. (1988) Reduction of incorrect antibiotic dosing through a structured educational order form. Archives of Internal Medicine 148: 1720-1724.

Aylward P (1996) Acute myocardial infarction: early treatment. Australian Prescriber 19: 52-54.

Bates D, Spell M, Cullen D, et al. (1997) The costs of adverse drug events in hospitalized patients. JAMA 277(4): 307-311.

Bero L, Cho MK (1994) Instruments for assessing the quality of drug studies published in the medical literature. JAMA 272(2): 101-104.

Biomed (2000) Appraisal of guidelines for research and evaluation in Europe (AGREE) instrument, 2nd draft, BIOMED project PL96-3669; site Internet: http://www.agreecollaboration.org

Crawford S, Santell JP (1994) ASHP national survey of pharmaceutical services in federal hospitals - 1993. American Journal of Hospital Pharmacy 51: 2377-2393.

Essential Drugs Programme South Africa (1998) Standard treatment guidelines and essential drug lists for (1) primary health care level, (2) hospital level adults, (3) hospital level paediatrics. National Department of Health, Pretoria; site Internet http://www.doh.gov.za; http://pharmis.pwv.gov.za/publications1.htm

Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M (1990) Changing surgical antimicrobial prohylaxis practices through education targeted at senior department leaders. Infection Control in Hospital Epidemiology 11: 578-583.

Fibrinolytic Therapy Trialists Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343(742): 311-322.

Fowkes FGR, Fulton PM (1991) Critical appraisal of published research: introductory guidelines. BMJ 1991; 302: 1136-1140.

Frick MH, Elo O, Haapa K, et al. (1987) Helsinki heart study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia. New England Journal of Medicine 317: 1237-1245.

Grimshaw JG, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342: 1317-1322.

Hadiyono JE, Suryawati S, Sulanto S, Sunartono D, Santoso B (1996) Interactional group discussion: results of a controlled trial using a behavioural intervention to reduce the use of injections in public health facilities, Social Science and Medicine 42(8): 1177-1183.

Hogerzeil H (1995) Promoting rational drug use: an international perspective. British Journal of Clinical Pharmacology 39: 1-6.

Holloway KA, Gautam BR, Reeves BC (2001a) The effects of different kinds of user fee on prescribing quality in rural Nepal. Journal of Clinical Epidemiology 54: 1065-1071.

Holloway KA, Gautam BR, Reeves BC (2001b) The effects of different kinds of user fee on prescribing costs in rural Nepal. Health Policy and Planning 16(4): 421-427.

Ilet KF, Johnson S, Greenhill G, et al. (2000) Modification of general practitioner prescribing of antibiotics by use of a therapeutics advisor (academic detailer). British Journal of Clinical Pharmacology 49(2): 168- 173.

Kafuko J, Zirabumuzale C, Bagenda D (1994) Rational drug use in rural health units in Uganda: effect of national standard treatment guidelines on rational drug use. UNICEF, Washington, DC.

Laing R, Hogerzeil HV, Ross-Degnan D (2001) Ten recommendations to improve the use of medicines in developing countries. Health Policy and Planning 16(1): 13-20.

Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1206.

MSH (1996) Manual for the development and maintenance of hospital drug formularies. Russia Rational Pharmaceutical Management Project. Management Sciences for Health, Arlington, VA; site Internet: http://www.msh.org

MSH (1997) Managing drug supply, 2nd edn. Management Sciences for Health, Kumarian Press, West Hartford, CT. ISBN: 1-56549-047-9.

MSH (publication annuelle) International drug price indicator guide. Publié par Management Sciences for Health en collaboration avec l'OMS; sites Internet: http://www.msh.org/publications; http://erc.msh.org; http://www.who.int/medicines/organization/par/ipc/drugpriceinfo.shtml

Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (1995) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC. ISBN: 1-55581-086-1.

O'Brien MA, Oxman AD, Davis DA, et al. (2000) Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Systematic Review (2): CD000409.

OMS (1980) Pharmacopée internationale, 3e édition, vol. 1: Méthodes générales d'analyse. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254150-8.

OMS (1981) Pharmacopée internationale, 3e édition, vol. 2: Normes de qualité. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254151-6.

OMS (1987a) L' usage rationnel des médicaments: rapport de la Conférence d' experts, Nairobi, 25-29 novembre 1985. Organisation mondiale de la Santé, Genève. ISBN: 92-4-256105-3.

OMS (1987b) Tests simplifiés pour les substances pharmaceutiques. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254204-0.

OMS (1988a) Critères éthiques applicables à la promotion des médicaments. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254-239-3

OMS (1988b) Pharmacopée internationale, 3e édition, vol. 3: Normes de qualité. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254215-6.

OMS (1992a) Tests simplifiés pour les préparations pharmaceutiques. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254418-3.

OMS (1993) Comment étudier l'utilisation des médicaments dans les services de santé: quelques indicateurs de l'utilisation des médicaments. Organisation mondiale de la Santé, Genève. WHO/DAP/93.1.

OMS (1994a) Injection use and practices in Uganda. Organisation mondiale de la Santé, Genève. WHO/DAP/94.18.

OMS (1994b) Pharmacopée internationale, 3e édition, vol. 4: Epreuves, méthodes et normes générales; normes de qualité pour les substances, excipients et préparations pharmaceutiques. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254462-0.

OMS (1997) Bien prescrire les médicaments: guide pratique. Organisation mondiale de la Santé, Genève. WHO/DAP/94.11.

OMS (1999a) Quality assurance of pharmaceuticals: a compendium of guidelines and related materials, vol. 2: Good manufacturing practices and inspection. Organisation mondiale de la Santé, Genève. ISBN: 92-4-154526.

OMS (1999b) Medical products and the Internet: a guide to finding reliable information. Organisation mondiale de la Santé, Genève. WHO/EDM/QSM/99.4.

OMS (1999c) Tests simplifiés pour les médicaments: substances pharmaceutiques, préparations à base de plantes et préparations pharmaceutique. Organisation mondiale de la Santé, Genève. ISBN: 92-4-254513-9.

OMS (2000) L'utilisation des médicaments essentiels. Rapport du comité OMS d'experts. Série de Rapports techniques NA 895. Organisation mondiale de la Santé, Genève. ISBN: 92-4-220895-7.

OMS (2002a) The selection and use of essential medicines (includes the WHO Model List of Essential Medicines) Report of the WHO Expert Committee. Technical Report Series No. 914, Organisation mondiale de la Santé, Genève; site Internet: http://www.who.int/medicines/organization/par/edl/expertcomm.shtml

OMS (2002b) WHO model formulary. Organisation mondiale de la Santé, Genève. ISBN:92-4-154559-3; site Internet: http://www.who.int/medicines/organization/par/formulary.shtml

OMS (2002c) Promouvoir l' usage rationnel des médicaments: éléments principaux. Perspectives politiques de l'OMS sur les médicaments NA 5, OMS/EDM. Organisation mondiale de la Santé, Genève.

OMS (2002d) Protocole d'évaluation des systèmes nationaux de surveillance et de riposte concernant les maladies transmissibles: directives pour les équipes d'évaluation. Organisation mondiale de la Santé, Genève. WHO/CDS/CSR/ISR/2001.2.

OMS (2003) International pharmacopoeia, 3rd edn, vol. 5: Tests and general requirements for dosage forms: quality specifications for pharmaceutical substances and tablets. Organisation mondiale de la Santé, Genève. ISBN: 92-4-154536-4.

OMS/UNICEF/FNUAP/Banque mondiale (1999) Principes opérationnels de bonnes pratiques pour les achats de produits pharmaceutiques. Organisation mondiale de la Santé, Genève. WHO/EDM/PAR/99.5.

Phillips D, Christenfeld N (1998) Increase in U.S. medication error deaths between 1983 and 1993. Lancet 351(9103): 643-644.

SIGN (1999) An introduction to SIGN methodology for the development of evidence-based clinical guidelines. SIGN Publication no. 39, Scottish Intercollegiate Guidelines Network, Edinburgh; site Internet: http://www.sign.ac.uk

Therapeutic Guidelines Ltd (2000) Therapeutic guidelines: antibiotics, 11th edn. Therapeutic Guidelines Ltd, North Melbourne, Victoria, Australia. ISSN: 1329-5039; site Internet: http://www.tg.com.au

Weekes LM, Brooks C (1996) Drugs and therapeutics committees in Australia: expected and actual performance. British Journal of Clinical Pharmacology 42(5): 551-557.

Wenzel R, Edmond M, Pittet D, et al. (1998) A guide to infection control in the hospital. An official publication of the International Society for Infectious Diseases. B.C. Decker Inc., Hamilton, Ontario, Canada; site Internet: http://www.bcdecker.com

Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-530.

Zimbabwe DTC Manual (1999) Establishing an effective drug & therapeutics committee: a practical manual developed in Zimbabwe. National Drug and Therapeutics Policy Advisory Committee, October 1999.